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Gene disruption technologiesThe mechanisms that regulate skeletal muscle differentiation, ﬁber type diversity and muscle regeneration
are incompletely deﬁned. Forkhead transcription factors are critical regulators of cellular fate determination,
proliferation, and differentiation. We identiﬁed a forkhead/winged helix transcription factor, Foxj3, which
was expressed in embryonic and adult skeletal muscle. To deﬁne the functional role of Foxj3, we examined
Foxj3 mutant mice. Foxj3 mutant mice are viable but have signiﬁcantly fewer Type I slow-twitch myoﬁbers
and have impaired skeletal muscle contractile function compared to their wild type controls. In response to a
severe injury, Foxj3 mutant mice have impaired muscle regeneration. Foxj3 mutant myogenic progenitor
cells have perturbed cell cycle kinetics and decreased expression of Mef2c. Examination of the skeletal
muscle 5′ upstream enhancer of the Mef2c gene revealed an evolutionary conserved forkhead binding site
(FBS). Transcriptional assays in C2C12 myoblasts revealed that Foxj3 transcriptionally activates the Mef2c
gene in a dose dependent fashion and binds to the conserved FBS. Together, these studies support the
hypothesis that Foxj3 is an important regulator of myoﬁber identity and muscle regeneration through the
transcriptional activation of the Mef2c gene.
Published by Elsevier Inc.Introduction
The molecular networks that govern muscle differentiation,
ﬁber diversity and muscle regeneration remain incompletely
deﬁned. Previous studies have uncovered an essential role for the
basic helix loop helix (bHLH) MyoD family members (i.e., MyoD,
myf5, MRF4 and myogenin) and myocyte enhancer factor 2 (Mef2)
factors, but the repertoire of interacting factors and upstream
regulators that coordinately regulate skeletal muscle differentiation
and ﬁber type speciﬁcation remain an area of intense interest.
Studies have demonstrated that the bHLH MyoD factors interact
with Mef2 factors to synergistically coactivate the myogenic
program. Global elimination of Mef2c results in early embryonic
lethality due to cardiovascular defects (Lin et al., 1997). Condi-forkhead binding site; Mef2c,
lactosidase; bHLH, basic Helix-
fast red; WT, wild type; GFP,
ﬁcation of eagle media; ES,
on; EDL, extensor digitorum
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Inc.tional elimination of Mef2c in skeletal muscle revealed a role in
ﬁber type speciﬁcation as there was a signiﬁcant decrease in Type I
oxidative slow myoﬁbers (Potthoff et al., 2007). While efforts have
focused on downstream targets of Mef2c, few direct upstream
regulators of Mef2c have been identiﬁed in the skeletal muscle
lineage.
Forkhead/winged helix transcription factors perform an array of
functions including fate speciﬁcation, pattern formation, cellular
proliferation, cellular differentiation and organogenesis (Lehmann et
al., 2003). Members of the forkhead/winged helix transcription
factors function through a DNA-binding dependent mechanism or
alternatively through protein–protein interactions to regulate gene
expression (Wijchers et al., 2006). For example, the forkhead/
winged helix factor, Foxk1, is expressed in myogenic progenitor cells
and functions as a cell cycle regulator by regulating the cyclin-
dependent kinase inhibitor, p21KIP(Garry et al., 2000). Mice lacking
Foxk1 have perturbed skeletal muscle regeneration due to impaired
activation/proliferation of the myogenic progenitor cell population
(Hawke et al., 2003a). In addition to Foxk1, other forkhead factors
including FoxO factors modulate cell signaling pathways, growth and
atrophy of adult skeletal muscle (Sandri et al., 2004). These studies
suggest that forkhead factors have critical roles in the regulation of
skeletal muscle development and regeneration.
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lineages, we undertook a candidate based screen. Using this strategy,
we identiﬁed Foxj3 as being signiﬁcantly upregulated in differentiat-
ing myoblasts. To further explore the functional role of Foxj3 in vivo,
we obtained a Foxj3 gene-targeted ES cell line and generated mutant
mice that have a β-geo cassette ﬂanked by two splice acceptors
inserted into the Foxj3 locus. The resulting mutant Foxj3 allele
produces a transcript that encodes exons 1–5 (1–176 amino acids) of
the Foxj3 protein that lacks a transcriptional activation domain. Mice
homozygous for both the mutant alleles (referred to as Foxj3m/m)
are viable, but have impaired skeletal muscle contractility and
decreased Type I oxidative myoﬁbers compared to their wild type
controls. In addition, Foxj3m/m mice have impaired skeletal muscle
regeneration following injury, impaired cell cycle kinetics of the
myogenic progenitor cell population and decreased expression of
Mef2c. Examination of the 5′ upstream skeletal muscle enhancer of
Mef2c revealed a highly conserved forkhead binding site (FBS).
Transcriptional assays in C2C12 myoblasts demonstrated that Foxj3
activates aMef2c-luciferase reporter andmutagenesis of the FBS in the
Mef2c skeletal muscle enhancer ablates this transcriptional activation.
Together these studies reveal that Foxj3 is a transcriptional activator
of Mef2c, and is an important regulator for adult muscle ﬁber type
identity and skeletal muscle regeneration.
Results
We have utilized an array of techniques to deﬁne the expression of
forkhead family members in the skeletal muscle lineage during
development and regeneration. To complement these studies, we
utilized a C2C12 myoblast differentiation assay to analyze gene
expression during discrete phases of myogenesis (Shi and Garry,
2006). We identiﬁed a novel member of the forkhead/winged helix
family, Foxj3, which was dynamically expressed during C2C12
myogenic differentiation using semi-quantitative RT-PCR (Fig. 1 and
Supplemental Figure S1). This differentiation assay revealed that
Foxj3 and Mef2c preceded myoglobin expression during myogenesis.
These studies support the hypothesis that Foxj3 is expressed and
regulated during myogenesis.
Generation of Foxj3m/m mice
To deﬁne the functional role of Foxj3, we generated Foxj3 mutant
mice (referred to as Foxj3m/m) from a BayGenomics© ES cell
“trapped” line (Stryke et al., 2003). The Foxj3 trapped ES cell line
contained an insertion of a β-galactosidase/neomyocin (β-geo)
cassette with two separate splice acceptors (Fig. 2A). The resulting
mRNA predicted transcript encodes exons 1 through 5 and contains all
but the last six residues of the forkhead DNA-binding domain. No
transcripts were detected following exon 6 of the native Foxj3 gene
(Figs. 2A–C). Previous studies using Gal4 transcriptional assays
demonstrated that the carboxy-terminus harbors the activation
domain of Foxj proteins and is essential for Foxj family of proteinsFig. 1. Foxj3 is expressed in C2C12 myoblasts. Semiquantitative RT-PCR analysis of
transcript expression during C2C12 differentiation from myoblasts (50% or 90%
conﬂuency, cultured in growth medium or GM) to myotubes (day 1 or d1 to day 4 or
d4, cultured in differentiation medium or DM) demonstrates that Foxj3 is expressed in
myoblasts prior to myoglobin (Mb) expression. Rn18s was used as a loading control.
(−) represents a negative control (lacking reverse transcriptase).functional activity (Pérez-Sánchez et al., 2000). Thus, we hypothe-
sized that the fusion protein encoded from Foxj3m/m mice would
result in a nonfunctional, transcriptionally inactive fusion protein.
Additionally, we predicted that the Foxj3-β-gal fusion protein would
recapitulate Foxj3 endogenous expression patterns.
Foxj3 mutant mice are viable
Mice homozygous for the Foxj3-β-geo targeted allele were
generated from matings of heterozygote mice. Initially, our studies
utilized the C57/B6J:129OlaP2Hsd mixed strain; however, we have
backcrossed the original chimeric mice with inbred C57/B6J and
129OlaP2Hsd strains separately and over six generations and we
observed no strain variances. Mice homozygous with the Foxj3
mutant alleles, generated from heterozygote matings, were viable and
born at normal Mendelian ratios (Supplemental Figure S2). Semi-
quantitative RT-PCR of gastrocnemius skeletal muscle from wildtype
and homozygous Foxj3 mutant mice revealed that expression of the
Foxj3mRNA transcript was as predicted limited to exons 1–5, and that
the carboxy-terminal activation domain in exons 8–12 were not
transcribed (Fig. 2C).
Foxj3m/m mice have impaired skeletal muscle regeneration
following injury
As previously described (Landgren and Carlsson, 2004), Foxj3 was
expressed in the myogenic lineage during embyogenesis (Supple-
mental Figure S3) and in the in vitro myogenic differentiation assay
(Fig. 1 and Supplemental Figure S1). We then examined the ability of
Foxj3m/mmice to regenerate their skeletal muscle following a severe
myonecrotic injury which destroys approximately 90% of the adult
skeletal muscle. In response to this cardiotoxin-induced injury, wild
type skeletal muscle regenerates within a 2-week period and has
restoration of its architecture. In contrast, Foxj3 mutant mice had a
severe regenerative impairment that was evident at 2 and 3 weeks
following delivery of cardiotoxin. We observed persistent myonecro-
sis and widespread replacement of the myoﬁbers with adipocytes
(Fig. 2D). Using electron microscopy, we observed the presence of
myogenic progenitor cells (i.e., satellite cells) in the unperturbed
Foxj3m/m skeletal muscle and there were no signiﬁcant differences
in their number compared to the gender and age matched control
mice (Supplemental Figure S4 and data not shown).
Foxj3 mutant myogenic progenitor cells have an increased proliferative
capacity
To determine the proliferative capacity of themutant andwildtype
myogenic progenitor cell population, we performed cell cycle kinetics
assay and an in situ proliferation assay. We isolated myogenic
progenitor cells from wild type and mutant skeletal muscle and
analyzed the cell cycle kinetics in asynchronized proliferating cells.
The mutant myogenic progenitor cells had a signiﬁcant decrease in
the G0/G1 phase and a signiﬁcant increase in the G2/M phase as
assayed by ﬂow cytometry (pb0.05; n=3 littermate pairs) (Figs. 3A
and B). These cell cycle results were further supported using the
proliferation marker Ki67 (which labels all proliferating cells) in
regenerating Foxj3 mutant vs. control skeletal muscle performed 5
days following cardiotoxin induced injury. These results demonstrate
an increased proliferative capacity, as measured by Ki67 expression
(Fig. 3C) that represented a 65% increase compared to the wild type
control (pb0.05; n=3) (Fig. 3D). Additionally, most of the Ki67-
positive cells were also positive for MyoD expression, which supports
the notion that the impaired regenerative defect may also be due in
part to increased proliferation of the mutant myogenic progenitor
cells (Fig. 3E). Importantly, we observed no signiﬁcant differences in
Ki67 expression in unperturbed Foxj3 mutant and wild type control
Fig. 2. Foxj3m/m mice have impaired skeletal muscle regeneration. (A) Schematic outlying the Foxj3-β-geo “gene trapped” locus. (B) PCR genotyping of tails from Foxj3 mice. (C)
The Foxj3 mutant transcript in Foxj3m/m gastrocnemius cDNA does not encode beyond exon 5 using RT-PCR techniques. Note that the transcript is ampliﬁed up to exon 5 in the
Foxj3m/m muscle; however, only the wild type transcript can be ampliﬁed from exon 6 and beyond. (D) Histological sections of WT (+/+) and Foxj3m/m gastrocnemius skeletal
muscle uninjured, 2 weeks, and 3 weeks post-cardiotoxin injury from 3-month-old male littermates. Note that the wild type skeletal muscle is fully regenerated with restoration of
skeletal muscle architecture within two weeks (note central nuclei representing regenerated myoﬁbers). Conversely, theFoxj3m/m cardiotoxin injured skeletal muscle fails to fully
regenerate up to 3 weeks postinjury. Black arrowheads mark areas of necrosis and adipogenesis that form and replace myoﬁbers following injury in the Foxj3m/m mice.
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the studies revealing no signiﬁcant differences in the number of
myogenic progenitor cells using electron microscopy or TUNEL-
positive cells in Foxj3m/m vs. control unperturbed skeletal muscle
further support the conclusion that Foxj3 is important in cell cycle
regulation as opposed to having a role in the maintenance of the
myogenic progenitor cell population (Supplemental Figure S4).
shRNA knockdown of endogenous Foxj3 results in increased myoblast
proliferation
To validate the in vivo increased myoblast proliferation phenotype
observed in the injured Foxj3m/mmice, we undertook shRNA knock-
down of endogenous Foxj3 in C2C12 myoblasts. Using four separate
shRNA and an empty vector control, we observed knockdown of Foxj3
transcript in two out of the four shRNA constructs examined (Fig. 4A).
Knockdown of endogenous Foxj3 in C2C12 myoblasts resulted in
increased proliferation of Foxj3 myoblasts and an induction of cells in
the proliferative phase of the cell cycle (Figs. 4B and C). No evidence of
cellular death was observed in any of the samples (n=3 replicates,
performed in three separate experiments).
Foxj3m/m skeletal muscles have decreased Type I ﬁbers and
impaired contractility
We next examined the ﬁber type diversity of the oxidative, slow
twitch soleus muscle and the glycolytic fast twitch EDL muscle inadult Foxj3m/m male mice using metachromatic ATPase ﬁber type
analysis. We observed that both the soleus and EDL muscles of the
Foxj3m/mmice had decreased numbers of oxidative Type I ﬁbers and
signiﬁcantly increased numbers of Type IIa/b ﬁbers compared to their
wild type controls (Figs. 5A–C; n=3; ⁎, pb0.05).
We next assessed the ability of the muscles to produce stress
(force normalized to muscle cross sectional area; Grange et al., 2002)
to determine if any functional deﬁcits existed in the Foxj3m/m
muscles resulting from the shift in ﬁber types. Compared to WT
controls, Foxj3m/m EDL muscles (Fig. 5D) had decreased stress (with
increased stimulation frequency compared to the wild type control;
n=6; pb0.05), but stress was minimally effected in the soleus
(Fig. 5E). These results establish that Foxj3 is important for ﬁber type
diversity and physiological function of skeletal muscle.Foxj3 functions as a transcriptional activator of gene expression
We next undertook a series of transcriptional assays to evaluate
the functional role of Foxj3 as a modulator of gene transcription. We
utilized an in vitro Gal4-UAS-luciferase reporter-based assay in C2C12
myoblasts (Chang et al., 2005). The Foxj3 full length construct
(containing the entire open reading frame) and the Foxj31-176 aa mu-
tant transcript were fused to the Gal4-DNA binding domain and
transfected with a UAS-luciferase reporter into C2C12 myoblasts.
Overexpression of the full-length Gal4-Foxj3 and the truncated
transcripts were expressed in the nuclear compartment (Supplemen-
tal Figure S5A and S5B). Overexpression of the full length Gal4-Foxj3
Fig. 3. Foxj3m/mMPCs have perturbed cell cycle kinetics. (A) Flow cytometry proﬁle of wild type and Foxj3m/mMPCs reveals that mutant MPCs have decreased number of cells in
the G0/G1 stage and increased cells in the G2/M stage of the cell cycle. (B) Table outlines quantitative results of experiments undertaken in panel A representing the average cell
cycle kinetics of WT and Foxj3m/m MPCs (n=3 separate experiments; ⁎pb0.003). (C) Ki67 immunostaining of WT and mutant injured skeletal muscle reveals increased
proliferation in the absence of Foxj3 following injury. (D) Quantitation of the Ki67 immunostaining reveals approximately a 65% increase in cellular proliferation in the Foxj3m/m
injured skeletal muscle (⁎pb0.05). (E) Immunohistochemical staining of MyoD (red) and Ki67 (green) expression following injury. White arrowheads indicate that a population
Ki67 positive cells are also positive for MyoD expression. A sub-population of cells are also positive for Ki67 (black arrowheads) but not myogenic (MyoD negative) in regenerating
skeletal muscle.
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dependant fashion (Supplemental Figure S5C; n=3;⁎, pb0.05)
whereas the Foxj31-176 aa mutant transcript had no transcriptional
activity)(Supplemental Figure S5D). These results support the
hypothesis that Foxj3 functions as a transcriptional activator of gene
expression.
Mef2c is a direct downstream target gene of Foxj3 in myoblasts
To identify potential downstream target genes of Foxj3, we utilized
oligonucleotide microarray technology to examine dysregulated
genes in Foxj3m/m myogenic progenitor cells. We identiﬁed over
900 genes that were signiﬁcantly dysregulated (pb0.005) greater
than two-fold and validated several of the most dysregulated
transcripts by semiquantitative RT-PCR (Fig. 6A). Analysis of the
Foxj3 dysregulated transcripts suggested that this forkhead protein
regulated a Mef2c-dependent pathway as a number of the down-
regulated transcripts contained Mef2c-binding elements within theirpromoters. Recent studies have validated a number of these down-
regulated transcripts (troponins I and T, myomesin2) as direct Mef2c
downstream target genes (Blais et al., 2005). Myocyte enhancer factor
2C (Mef2c) was downregulated more than 10-fold in the Foxj3
mutant myoblasts compared to the wild type controls. In addition, we
observed that Mef2c target genes were also downregulated including
Tnni1 and Tnnt2 (Fig. 6A). Upon examination of the 5′ upstream
promoter of Mef2c, we identiﬁed a highly conserved forkhead binding
site within the skeletal muscle enhancer region (−1.1 kb /+77 bp,
Wang et al., 2001) (Fig. 6B). Using transgenic technology, Wang and
colleagues demonstrated that this 1.2 kb skeletal muscle enhancer
region directs lacZ reporter expression exclusively in embryonic and
adult skeletal muscle lineages. To conﬁrm our hypothesis that Foxj3
was able to bind to the evolutionary conserved FBS and was a direct
regulator of Mef2c in vivo, we performed a chromatin immunopre-
cipitation (ChIP) assay and PCR with primers speciﬁc for the FBS
located in the Mef2c 5′ upstream skeletal enhancer region. When we
overexpressed the Foxj3-GFP fusion construct in C2C12 myoblasts,
Fig. 4. shRNA knockdown of endogenous Foxj3 results in increased myoblast proliferation. (A) Real-time PCR conﬁrming knockdown of endogenous Foxj3 transcript in cells
transfected with shRNA directed against Foxj3 (n=3 replicates; ⁎pb0.05). (B) Phase microscopy of C2C12 myoblasts 48 h post-transfection of both control (pRS; empty vector) and
shRNA directed against mouse Foxj3; shRNA #1 and #2. Note increased number of myoblasts with knockdown of Foxj3. (C) Table summarizing the results of the FACS histogram
proﬁles of the C2C12 myoblasts transfected with control and shRNA Foxj3 vectors (n=3 replicates; ⁎pb0.03; ⁎⁎pb0.003).
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the 1.2 kb Mef2c skeletal muscle enhancer was ampliﬁed, but not in
the negative IgG control (Fig. 6C). These studies support the
conclusion that Foxj3 binds to the Mef2c promoter in vivo.
Basedon the results of theChIP assayand theevolutionary conserved
region of the Mef2c promoter, we fused the−1.1 kb/+77bp (referred
to as 1.2 kb Mef2c) to a luciferase reporter and transfected C2C12
myoblastswith increasing amounts of Foxj3. Using these transcriptional
assays, we observed that Foxj3 trancriptionally activated the 1.2 kb
Mef2c-luc up to 12-fold in a dose dependant fashion (Fig. 6D and E). The
Foxj31-176 aamutant transcript thatwasproduced in the Foxj3m/mmice
had essentially no transcriptional activity (Supplemental Figure S5E and
S5H). Using site-directedmutagenesis,wemutated the forkheadbinding
site (FBS) in the 1.2 kb Mef2c-luc reporter, and noted that over-
expression of Foxj3 in C2C12 myoblasts lacked any transcriptional
activity (Figs. 6D and E). Collectively, these studies support the
conclusion that Foxj3 is a direct upstream regulator of the Mef2c gene.
Discussion
Molecular networks coordinately regulate skeletal myogenesis
during embryogenesis and regeneration of adult skeletal muscle.
Many of these transcriptional networks (MyoD family members,
Mef2 factors, Pax3, Pax7, Foxk1, etc.) have been deﬁned using gene
disruption strategies that conﬁrmed or uncovered novel essential
roles in developing and regenerating muscle (reviewed by Shi and
Garry, 2006). While intense interest has focused on downstream
pathways that impact muscle differentiation and ﬁber type
speciﬁcation, the upstream regulators are incompletely deﬁned. In
the present study, we have begun to further decipher the
regulators of the myogenic program by making three principalﬁndings. First, we utilized molecular technologies to generate Foxj3
mutant mice (not Foxj3 null mice) that were viable. Importantly,
we recognize that this genetic model may produce a truncated
functional Foxj3 protein. As Foxj3 is expressed in skeletal muscle,
we examined the skeletal muscle regenerative capacity in Foxj3
mutant mice. We observed that mutant Foxj3 mice had impaired
muscle regeneration.
Another forkhead transcription factor, Foxk1, has been implicated
as essential for normal skeletal muscle regeneration (Garry et al.,
2000). However, the Foxj3m/m regenerative phenotype exhibits
considerable differences with the Foxk1 null phenotype. Foxk1 is
restricted to the MPC population and mice lacking Foxk1 have
perturbed skeletal muscle regeneration due to decreasedMPCs and an
inability to efﬁciently activate theMPC population (Garry et al., 2000).
In contrast, these studies emphasize that while the absence of either
forkhead factor results in impaired muscle regeneration, the under-
lying mechanism is distinct for both Foxj3 and Foxk1.
A second major ﬁnding of the present study is that Foxj3 is an
important cell cycle regulator. While no proliferative changes were
observed in the unperturbed Foxj3m/m skeletal muscle, our in vivo
studies (following cardiotoxin injury) and in vitro studies (isolation
and activation of the MPC population) demonstrate that Foxj3 is an
antiproliferative factor.While themechanistic detail regarding Foxj3's
antiproliferative role is incompletely deﬁned, one possible mecha-
nism involves decreased Mef2c expression. Previous studies have
demonstrated that Mef2c interacts with the RNA helicase, CHAMP
(Mov10l1), which induces the cyclin dependent kinase inhibitor
p21KIP (cdkn1a) in striatedmuscle to promote cellular quiescence (Liu
and Olson, 2002). Many other forkhead factors have repressive and
permissive (Foxk1) inﬂuences on cell cycle kinetics and therefore
have important regulatory roles during embryogenesis, growth and
Fig. 5. Foxj3 is essential for the determination of adult myoﬁber identity. (A) Metachromatic ATPase staining of EDL and soleus skeletal muscles of WT and Foxj3m/mmice. Foxj3m/
mmuscles have decreased numbers of Type 1 oxidative slow-twitch ﬁbers and increased numbers of Type IIa/b fast twitch ﬁbers. (B) Quantitation of Type 1 ﬁbers in wild type and
Foxj3m/m EDL muscles (n=4 separate muscles; 3 littermate pairs; ⁎pb0.05) reveals decreased Type 1 ﬁbers compared toWT control. (C) Quantitation of Type 1 ﬁbers in wild type
andFoxj3m/m soleus muscles (n=4 separate muscles; 3 littermate pairs; ⁎pb0.05) reveals decreased Type 1 ﬁbers compared to WT control. (D and E) Isolated wild type and
Foxj3m/m EDL (D) and soleus (E) skeletal muscle stress-frequency responses. Both the EDL and soleus muscles of the Foxj3 mutant mice showed a right shift in the stress–frequency
relationship compared to their wild type littermates (n=4 separate muscles; 3 littermate pairs; ⁎pb0.05).
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transcription factor that regulates cell cycle progression in the muscle
lineage.
A third major ﬁnding of this study is that Foxj3 is a transcriptional
activator of Mef2c. The Fox transcription factor family has a number
of members such as the FoxO family that directly regulate gene
expression and impact muscle growth and function. For example,
Foxo3 has been shown to transcriptionally activate the ubiquitin
ligase, atrogin-1 gene that results in atrophy of the myoﬁbers (Sandri
et al., 2004). In the present study, we utilized transcriptome analysis,
transcriptional assays, mutagenesis and binding studies to support
the conclusion that Foxj3 is a direct upstream activator of the Mef2c
gene.
Mice lacking Mef2c are embryonic lethal at E9.5 due to
cardiovascular defects (Lin et al., 1997). While the role of Mef2c in
the heart has been elucidated in the past few years, the exact role of
Mef2c in skeletal myogenesis is unclear (reviewed by Berkes and
Tapscott, 2005). A recent study utilizing a temperature sensitive
Drosophila Mef2 orthologue (dMEF2), surprisingly revealed that
dMEF2 was not essential for adult myogenesis (Baker et al., 2005).
While ﬂies lacking dMEF2 had severe neurological deﬁcits and an
inability to ﬂy, they had normal patterning of skeletal muscle.
However, studies in vertebrates support a role for Mef2c in skeletal
myogenesis.
Recent studies undertaken by Hughes and colleagues demonstrat-
ed that simultaneous morpholino knockdown of zebraﬁsh Mef2c and
Mef2d resulted in a loss of thick ﬁlament proteins and the disruptionof sarcomeric structure (Hinits and Hughes, 2007). In addition, it has
been conclusively demonstrated that Mef2c is an essential upstream
transcriptional activator of troponins in skeletal muscle (Di Lisi et al.,
1998; Blais et al., 2005) and myoﬁber identity (Wu et al., 2000).
Conditional transgenic technologies have revealed a broader role for
Mef2c in cellular maintenance in various lineages. The conditional
deletion of Mef2c in skeletal muscle lineages using a MCK-Cre
transgenic line resulted in a severe decrease of type 1 ﬁbers (Potthoff
et al., 2007). Potthoff and colleages clearly demonstrated that HDAC-
mediated inhibition of Mef2c was the essential regulatory step in the
conversion of oxidative ﬁbers to slow-twitch, non-oxidative, fast-
twitch ﬁbers. The authors further demonstrated that the conditional
loss of Mef2c in the skeletal muscle lineage, results in decreased
expression of structural Mef2c target genes, including troponins I and
T and myomesin2.
In the Foxj3m/m skeletal muscle, we observed decreased
expression of Mef2c as well as decreased expression of the Mef2c
downstream target genes. The decreased expression of Mef2c and its
downstream targets resulted in perturbed ﬁber type speciﬁcation and
impaired contractility. The decrease in overall maximum stress output
in Foxj3 mutant mice could be the result of the decreased levels of
troponins as a consequence of Mef2c downregulation. This could lead
to decreased activation of the contractile apparatus. For reasons that
are not clear, the decrease in stress was greater in the EDL than the
soleus of the Foxj3 mutant mice. Together these results establish
Foxj3 is a modulator of myoﬁber identity through a likely MEF2-
dependent pathway.
Fig. 6.Mef2c is a direct downstream target of Foxj3 in skeletal muscle. (A) Semi-quantitative RT-PCR analysis of WT and Foxj3m/mMPCs reveals decreased expression of Mef2c and
Mef2c-dependent target genes in the absence of Foxj3. Decreased expression of Cdkn1a or p21KIP corresponds to the increased proliferative capacity of the mutant MPCs as
demonstrated in Fig. 3A. The housekeeping gene Gapdh is used as the loading control. (B) Homology alignment of the 5′ upstream Mef2c promoter reveals an evolutionarily
conserved forkhead binding site or FBS. (C) Chromatin immunoprecipitation (ChIP) of Foxj3 using primers for the FBS in the Mef2c skeletal muscle enhancer indicate that Foxj3
directly binds to the FBS. IgG and 10% total chromatin (Input) are shown as controls. (D) Schematic outlining the Mef2c upstream fragment that harbors the FBS (and corresponding
mutant construct) fused to the luciferase (luc) reporter constructs that were used in the transcriptional assays in panel E. (E) Foxj3 transcriptionally activates the Mef2c-luc skeletal
muscle enhancer reporter in a dose dependent fashion in C2C12 myoblasts (n=3; ⁎p b 0.005). Mutagenesis of the FBS ablates the ability of Foxj3 to transcriptionally activate the
Mef2c-luc reporter.
402 M.S. Alexander et al. / Developmental Biology 337 (2010) 396–404Collectively, these studies have identiﬁed a novel forkhead
transcriptional regulator, Foxj3 for Mef2c gene expression. Moreover,
Foxj3 mutant mice demonstrate a phenotype consistent with
decreased Mef2c expression and emphasize the role of Foxj3 in
skeletal muscle biology including cell cycle kinetics, ﬁber type
diversity and muscle regeneration.
Methods
Knockout mice
Foxj3 mutant mice were generated from the BayGenomics Foxj3-
trapped ES-cell line (XL913) of the129P2OlaHsd strain (Stryke et al.,
2003). After ES cell expansion and sequence conﬁrmation, the Foxj3-
trapped ES cells were injected into blastocysts, and chimeric mice
were born to foster mothers. Progeny that were greater than 90%
chimeric were then mated to both C56/B6J (Jackson Laboratory) and
the 129P2OlaHsd (Harlan) mice to ensure germline transmission.
Unless speciﬁed, wild type littermates from Foxj3 heterozygote
crosses were used for all experiments (See Supplemental Materials
and Methods for genotyping primers).
Mice were kept on a 4% fat irradiated chow (Harlan) diet and
exposed to standard 12-h light/dark cycles. Mouse weights were
recorded on a Mettler PE 200 scale. Mice were housed in a sterile,
pathogen-free animal facility. All animal protocols were approved by
the Institutional Animal Care and Use Committees at the University of
Texas Southwestern Medical Center at Dallas.
Immunohistochemistry/histochemistry of histological sections
All tissues were perfusion ﬁxed using 4% paraformaldehyde at 4 C
and washed in 1 PBS before sectioning. Sections were stained with
hemotoxylin and eosin, nuclear fast red, and other antisera as
previously described (Meeson et al., 2007).Skeletal muscle tissues/sections for ﬁber type analysis were
performed following cryoembedding of tissues in OCT (Tissue Tek)
and Gum Tragacanth (Sigma) mix as previously described (Meeson et
al., 2007). The protocol for metachromatic ATPase ﬁbertyping has
been previously described (Garry et al., 1996).Primers
All primers used in this study were from Operon, and RTPCR
primer sequences can be found in the Supplemental Materials and
Methods section.Plasmids
The murine Foxj3 gene (NM_172699; NCBI Gene Bank) consisting
of a 1869 base pair open reading framewas cloned into the pCDNA3.1-
NT-GFP (Invitrogen), pM1 (Gal4 vector) and the pCDNA3.1-N-myc
plasmids using standard techniques. Foxj3 constructs that contained
the amino terminus and the DNA-binding domain (Foxj31-176aa) were
cloned in frame in the same expression plasmids. The Gal4-UAS-
luciferase system has been previously described (McKinsey et al.,
2006). More detailed information about the plasmids used in these
studies is available upon request.
The Mef2c skeletal muscle-speciﬁc promoter (−1.1 kb/+77 bp)
containing the forkhead binding site has been previously described
(Wang et al., 2001). The promoter regionwas ampliﬁed from genomic
DNA and cloned into the pGL3-basic promoter with a minimal TATA
promoter (pGL3-TATA). Mutagenesis of the forkhead binding site in
the Mef2c-luciferase promoter construct was performed using the
QuikChange II Site-Directed Mutagenesis Kit (Strategene). The Mef2c
FBS was mutated using the mutant primer 5′ TAATAGGAA-
CAGGTGGGCGGCTACAAAGC 3′ and its reverse compliment.
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Unless otherwise noted, all transfections were performed using
C2C12 myoblasts grown in 20% fetal calf serum/DMEM (Gibco).
Transfections of 105 C2C12 myoblasts were performed in six-well
plates using a Lipofectamine (Invitrogen) kit, and total protein was
harvested 48 h post-transfection. Up to 2 μg of plasmid DNA was
transfected in serum-free Optimem media (Gibco). Luciferase assays
were performed using a Luciferase Assay System (Promega) following
themanufacturer's instructions. All fold changes were normalized to a
lacZ loading control, as previously described (Meeson et al., 2007).
Myotube differentiation was promoted by exposing 80% conﬂuent
myoblast cultures to differentiation medium (DMEM supplemented
with 2% heat inactivated horse serum, antibiotics, insulin and
transferrin) as previously described (Hawke et al., 2003b).
Antisera
The following antisera were used in these studies: mouse
monoclonal anti-Ki67 serum (Nova Castra; 1:1,000 dilution), rabbit
anti-GFP serum (Molecular Probes; 1:1,000 dilution) and mouse
monoclonal anti-MyoD serum (Nova Castra, 1:500 dilution). The
secondary antisera utilized in these studies included a FITC conjugat-
ed goat anti-mouse serum (1:50 dilution; Jackson ImmunoResearch)
and a rhodamine conjugated goat anti-rabbit serum (1:50 dilution;
Jackson ImmunoResearch).
Chromatin immunoprecipitation
Chromatin immunoprecipitation (ChIP) was performed using the
ChIP Kit-M for mammalian cells (Progeneron, Inc). C2C12 myoblasts
(2×106) were transfected with 4 μg Foxj3-GFP, and harvested for
nuclear protein 48 h post-transfection. Nuclear lysates were sonicated
using a 550 Sonic Dismembrator (Fisher Scientiﬁc) sonicator and
immunoprecipitated with 6 μg of anti-GFP serum (Molecular Probes)
overnight at 4 C. Selected samples were incubated with IgG (Sigma) as
an internal control. Lysates were then bound on UltralLink Immobi-
lized Protein A/G beads (Pierce), and chromatin was then puriﬁed
using Tripure (Roche) before elution in sterile water. 6 μL of ﬁve-fold
diluted input and antibody-bound chromatin were used in the PCR
reaction with primers speciﬁc for the region in the Mef2c skeletal
muscle enhancer containing the forkhead binding site (see Supple-
mental Materials and Methods).
Primary MPC isolation, culture and immunohistochemical analyses
As previously described (Meeson et al., 2007), primary MPC
cultures were established following the isolation of MPCs from
hindlimb skeletal muscle of 2-day-old neonatal mice. Cells were
preplated and cultured in F-10 growth medium (Gibco/Invitrogen)
supplemented with 25 ng/ml ﬁbroblast growth factor (Invitrogen).
WT and Foxj3m/m MPCs were isolated from postnatal day 2
littermate pups generated from Foxj3 heterozygote breeders. Asyn-
chronously dividing WT and Foxj3m/m MPCs were ﬁxed for 10 min
with 4% paraformaldehyde and immunostained as previously de-
scribed (Meeson et al., 2007).
Electron microscopy and satellite cell quantitation
As previously described (Meeson et al., 2007), tibialis anterior
muscles from 3 to 4 month old male adult WT and Foxj3m/m mice
were harvested, perfusion ﬁxed with 3% gluteraldehyde and postﬁxed
with buffered 1% osmium tetroxide. Samples were then dehydreated
with ethanol, embedded in Spurr resin, polymerized, sectioned and
placed on copper grids. Sections were examined using a JEOL 1200EXII TEM. MPCs were quantiﬁed using criteria as outlined previously
(Garry et al., 1997).Muscle physiology protocol
Both extensor digitorum longus (EDL) and soleus muscles were
dissected from anesthetized WT control and Foxj3m/m mice aged
130–190 days (2mg xylazine–20mg ketamine per 100 g of bodymass
i.p.). Muscles were incubated at 30 °C in an oxygenated (95% O2–5%
CO2) physiological salt solution (PSS; pH 7.6) containing (in
mM):120.5 NaCl, 4.8 KCl, 1.2 MgSO4, 20.4 NaHCO3, 1.6 CaCl2, 1.2
NaH2PO4, 10.0 dextrose, and 1.0 pyruvate. Muscles were prepared for
isometric contractions using a dual-mode servomotor system (300B,
Aurora Scientiﬁc) as previously described (Wolff et al., 2006). Resting
muscle force was set at 1.00 ± 0.05 g, (i.e., L0, muscle length at which
twitch force was maximal) that was automatically maintained by a
steppermotor (Wolff et al., 2006). The steppermotor was temporarily
inactive during isometric contractions. Dynamic Muscle Control
software (DMC Version 4.1.6, Aurora Scientiﬁc) was used to record
force output in response to electrical activation of the muscles via
closely ﬂanking platinum electrodes. Each EDL and soleus muscle was
subjected to a force-frequency (F-F; 1, 30, 50, 80, 100, 150 Hz)
protocol. Forces for the F-F protocol were converted to stress, or force
normalized to muscle cross sectional area, as described (Grange et al.,
2002). Physiological data were analyzed using a one-way ANOVA.
(JMP 7.0).Semiquantitative RT-PCR
Total RNAwas extracted from cells and homogenized tissues using
Tripure (Roche). 1 μg of total RNA was reverse transcribed using the
SuperScript First Strand Synthesis kit (Invitrogen). cDNA was then
diluted ten-fold in water, and PCR ampliﬁed using Go Taq Master Mix
(Promega), and visualized on 1% agarose gels stained with ethidium
bromide.shRNA experiments
Four separate sets of short hairpin RNA (shRNA; HuSH-29 kit,
Origene) directed against murine Foxj3 were cloned into the pRS
plasmid under the U6 promoter and used for transfection assays in
C2C12 myoblasts. The empty vector (pRS) and a nonsense (pRS-GFP)
plasmid were used as negative controls. Effectiveness of the Foxj3
knockdown was tested in C2C12 myoblasts using both semi-
quantitative RT-PCR for endogenous Foxj3. 0.5 μg of shFoxj3 or vector
was transfected into C2C12 myoblasts using lipofectamine (Invitro-
gen) in serum free Optimem (Gibco) media for 4 h. After 4 h, the
transfection media was replaced with growth media containing 20%
FBS in DMEM (Gibco). Cells were harvested 48 h post transfection for
RNA, protein, and cellular content in a manner previously described
(Meeson et al., 2007). Real-time PCR of Foxj3 was run following
reverse transcription of 1 μg of total RNA (Superscript II kit/
Invitrogen) using SYBRGreen Master Mix (Applied Biosystems).
Samples were run on an ABI Prism 7900 light cycler and data were
analyzed as previously described (Meeson et al., 2007).cDNA microarray data
Total RNAwas harvested fromwild type and Foxj3m/mmyoblasts,
and labeled for Affymetrix arrays as previously described (Goetsch et
al., 2003). cDNA microarray data can be accessed at the NCBI Gene
Expression Omnibus (accession number GSE10628).
404 M.S. Alexander et al. / Developmental Biology 337 (2010) 396–404Cardiotoxin-induced muscle regeneration
Cardiotoxin (Calbiochem) was delivered intramuscularly into the
gastrocnemius muscle of adult transgenic mice as previously
described (Meeson et al., 2007).
Statistical analysis
All non-physiological p-values were calculated using Student's t-
test (two-tailed) analysis.
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